Cure vs treatment
This new ideal wonder drug would be, like insulin, effective in remitting obvious adverse symptoms of the disease, but not effective in curing the underlying disease. Thus, it would be needed continually for the remaining life of the patient. It would have to be patentable; that is, it could not be a natural medication because these are non-patentable. Like insulin, it would be highly profitable to manufacture and distribute. Mandatory government approvals would be required to stimulate the use by physicians as a prescription drug. Testing required for these approvals would have to be enormously expensive to prevent other, unapproved, medications from becoming competitive.

This is the origin of the classic medical protocol of “treating the symptoms”. By doing this, both the drug company and the doctor could prosper in business and the patient, while not being cured of his disease, was sometimes temporarily relieved of some of his symptoms.
Additionally, natural medications that actually cured disease, would have to be suppressed. The more effective they were, the more they would need to be suppressed and their proponents jailed as quacks. After all, it wouldn’t do to have some cheap effective natural medication cure disease in a capital intensive monopoly market specifically designed to treat symptoms without curing disease. Often the natural substance really did cure disease. This is why the force of law was used to drive the natural, often superior, medicines from the market place, to remove the cure word from the medical vocabulary and to totally undermine the very concept of a free marketplace in the medical business.
Now it is clear why the cure word is so vigorously suppressed by law. The FDA has extensive Orwellian regulations that prohibit the use of the cure word to describe any competing medicine or natural substance. It is precisely because many natural substances do actually both cure and prevent disease that this word has become so frightening to the drug and orthodox medical community.
The commercial value of symptoms
After this redesign of drug development policy to focus on ameliorating symptoms rather than curing disease, it became necessary to reinvent the way drugs were marketed. This was done in 1949 in the midst of a major epidemic of insulin resistant diabetes.
In 1949, the US medical community reclassified the symptoms of diabetes, along with many other disease symptoms, into diseases in their own right. With this reclassification as the new basis for diagnosis, competing medical specialty groups quickly seized upon related groups of symptoms as their own proprietary symptom set. Thus the heart specialist, endocrinologist, allergist, kidney specialist, and many others started to treat the symptoms for which they felt responsible. As the underlying cause of the disease was widely ignored, all focus on actually curing anything was completely lost. By this new focus on treating symptoms, instead of curing disease, disease was now allowed to run rampant without any effective check on its progress. While not a very smart idea from the patients viewpoint, it did succeed in making the American medical community amongst the wealthiest in the world because of the continuing high volume of repeat business that it promoted
Heart failure for example, which had previously been understood to often be but a symptom of diabetes, now became a disease not directly connected to diabetes. It became fashionable to think that diabetes “increased cardio-vascular risk.” The causal role of a failed blood sugar control system in heart failure became obscured. Consistent with the new medical paradigm, none of the treatments offered by the heart specialist actually cures, or is even intended to cure, their proprietary disease. For example, the three year survival rate for bypass surgery is almost exactly the same as if no surgery was undertaken.
Today over half of the people in America suffer from one or more symptoms of this disease. In its beginnings, it has become well known to physicians as Type II Diabetes, Insulin Resistant Diabetes, Insulin Resistance, Adult Onset Diabetes, or more rarely Hyperinsulinemia. According to the American Heart Association, almost 50% of Americans suffer from one or more symptoms of this disease. One third of our population is morbidly obese. Half of our population is overweight. Type II Diabetes, also called Adult Onset Diabetes, now appears routinely in six year old children
Many of our degenerative diseases can be traced to a massive failure of our endocrine system that was well known to the physicians of the 1930’s as Insulin Resistant Diabetes. This basic underlying disorder is known to be a derangement of the blood sugar control system by badly engineered fats and oils. It is exacerbated and complicated by the widespread lack of other essential nutrition that the body needs to cope with the metabolic consequences of these poisons.
All fats and oils are not equal. Some are healthy and beneficial; many, commonly available in the supermarket, are poisonous. The health distinction is not between saturated and unsaturated, as the fats and oils industry would have us believe. Many saturated oils and fats are highly beneficial; many unsaturated oils are highly poisonous. The important health distinction is between natural and engineered. There exists great dishonesty in advertising in the fats and oils industry. It is aimed at creating a market for cheap junk oils such as soy, cottonseed and rape seed oil. With an informed and aware public these oils would have no market at all and the US, and indeed the world, would have far less diabetes.